- Report
- October 2024
- 184 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- July 2024
- 175 Pages
Global
From €4753EUR$5,000USD£3,993GBP
- Report
- March 2025
- 89 Pages
Global
From €5324EUR$5,600USD£4,472GBP
- Report
- September 2023
- 98 Pages
Global
From €5656EUR$5,950USD£4,752GBP
- Report
- January 2024
- 182 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- April 2024
- 132 Pages
Global
From €903EUR$950USD£759GBP
The Cancer Immunotherapy Drug Discovery Outsourcing market is a subset of the larger Drug Discovery market. It focuses on the development of drugs that use the body's own immune system to fight cancer. This includes the development of monoclonal antibodies, small molecules, and other immunotherapies. Companies in this market provide services such as target identification, lead optimization, preclinical development, and clinical trial support.
Companies in the Cancer Immunotherapy Drug Discovery Outsourcing market include Charles River Laboratories, WuXi AppTec, Parexel, and Syngene International. Other companies in the Drug Discovery market include Evotec, Almac Group, and Piramal Pharma Solutions. Show Less Read more